Skip to main content

ADVERTISEMENT

Donald Ohloma, MS

Clinical Pathways GPS
03/08/2016
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Donald Ohloma, MS
Discontinuation of treatment should be considered whenever treatment benefits are exceeded by their burden. When and how patients should be discontinued from treatment, however, may not necessarily be addressed by a...
Discontinuation of treatment should be considered whenever treatment benefits are exceeded by their burden. When and how patients should be discontinued from treatment, however, may not necessarily be addressed by a...
...
03/08/2016
Journal of Clinical Pathways